Search Results - VOSKARIDOU E.

  • Showing 1 - 1 results of 1
Refine Results
  1. 1

    P-090: IS A DEDICATED MARKETING APPROVAL OF HYDROXYUREA IN SICKLE CELL DISEASE MAY INCREASE THE CLINICAL BENEFIT OF THE DRUG? by GALACTÉROS F., VOSKARIDOU E., HABIBI A., CANNAS G., JOSEPH L., LOKO G., DE MONTALEMBERT M.

    Published in HemaSphere (2022-08-01)
    Get full text
    Article


Search Tools: